Description
Product Overview
AOD 9604 is a synthetic peptide fragment derived from the C-terminal region of the human growth hormone (amino acids 176–191). This laboratory-grade compound is provided in lyophilized powder form and is designed for research into peptide structure, receptor interaction, and metabolic signaling. The molecular sequence includes specific amino acid residues that play a key role in lipid metabolism studies, making it a valuable tool for exploring biochemical pathways associated with energy regulation and adipose tissue response.
Chemical Characteristics
This peptide is composed of a defined amino acid chain with terminal modifications that enhance molecular stability and resistance to enzymatic degradation. The structure incorporates a disulfide bridge, which supports conformational integrity during experimental use. AOD 9604 is commonly utilized in in vitro analyses to study peptide receptor dynamics and the biochemical mechanisms related to growth hormone–derived fragments.
Specifications
- Compound: AOD 9604 (Fragment 176–191)
- Molecular Formula: C78H123N23O23S2
- Molecular Weight: 1815.07 g/mol
- Purity: ≥98% (HPLC)
- Form: Lyophilized peptide powder
- Unit Size: 5 or 10 mg per vial
- Storage: Store in a cool, dry place away from direct light
Intended Use
This compound is supplied For Research Use Only (RUO). It is not intended for human or veterinary use, medical applications, or diagnostic purposes. Handling should be performed only by qualified professionals in controlled laboratory settings following appropriate safety and regulatory guidelines.
Disclaimer
AOD 9604 is provided exclusively for in vitro research and educational use. This compound has not been evaluated by the FDA or any other regulatory authority. It is not intended to diagnose, treat, cure, or prevent any disease. Purchase and handling are restricted to trained researchers and licensed institutions operating within approved laboratory environments.
